EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies

Saudatu Chinade Ja'afaru iD, Adamu Uzairu, Sharika Hossain, Mohammad Hamid Ullah, Muhammed Sani Sallau, George Iloegbulam Ndukwe, Muhammad Tukur Ibrahim, Imren Bayil, Abu Tayab Moin iD

PLOS Neglected Tropical Diseases · 12.09.2024 · 18 (9) · e0012453

DOI: 10.1371/journal.pntd.0012453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 12.09.2024. Verfasst von Saudatu Chinade Ja'afaru und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Ahmadu Bello University, Zaria, Nigeria. Hauptthemen laut MEDLINE: Drug Design, Oxidoreductases Acting on CH-CH Group Donors, Quantitative Structure-Activity Relationship, Schistosoma mansoni. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schistosomiasis, also known as bilharzia or snail fever, is a tropical parasitic disease resulting from flatworms of the Schistosoma genus. This often overlooked disease has significant impacts in affected regions, causing enduring morbidity, hindering child development, reducing productivity, and creating economic burdens. Praziquantel (PZQ) is currently the only treatment option for schistosomiasis. Given the potential rise of drug resistance and the limited treatment choices available, there is a need to develop more effective inhibitors for this neglected tropical disease (NTD). In view of this, quantitative structure-activity relationship studies (QSAR), molecular docking, molecular dynamics simulations, drug-likeness, and ADMET predictions were applied to 31 inhibitors of Schistosoma mansoni Dihydroorotate dehydrogenase (SmDHODH). The designed QSAR model demonstrated robust statistical parameters including an R 2 of 0.911, R 2 adj of 0.890, Q 2 cv of 0.686, R 2 pred of 0.807, and cR 2 p of 0.825, confirming its robustness. Compound 26 , identified as the most active derivative, emerged as a lead candidate for new potential inhibitors through ligand-based drug design. Subsequently, 12 novel compounds ( 26A - 26L ) were designed with enhanced inhibition activity and binding affinity. Molecular docking studies revealed strong and stable interactions, including hydrogen bonding and hydrophobic interactions, between the designed compounds and the target receptor. Molecular dynamics simulations over 100 nanoseconds and MM-PBSA free binding energy (ΔG bind ) calculations validated the stability of the two best-designed molecules ( 26A and 26L ). Furthermore, drug-likeness and ADMET prediction analyses affirmed the potential of these designed compounds, suggesting their promise as innovative agents for treating schistosomiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignOxidoreductases Acting on CH-CH Group DonorsQuantitative Structure-Activity RelationshipSchistosoma mansoniAnimalsHumansAnthelminticsDihydroorotate DehydrogenaseDrug DiscoveryEnzyme InhibitorsLigandsMolecular Docking SimulationMolecular Dynamics SimulationSchistosomiasisSchistosomiasis mansoni

Substanzen

AnthelminticsDihydroorotate DehydrogenaseEnzyme InhibitorsLigandsOxidoreductases Acting on CH-CH Group Donors

Autor:innen und Institutionen

  • Department of Chemistry, Ahmadu Bello University, Zaria, Nigeria.
  • Department of Chemistry, Aliko Dangote University of Science and Technology, Wudil, Nigeria.
  • Department of Pharmacy, Jahangirnagar University, Savar, Dhaka, Bangladesh.
  • Department of Pharmacy, University of Cyberjaya Medical Science, Cyberjaya Selangor, Malaysia.
  • Department of Bioinformatics and Computational Biology, Gaziantep University, Gaziantep, Turkey.
  • Department of Genetic Engineering and Biotechnology, Faculty of Biological Sciences, University of Chittagong, Chattogram, Bangladesh.

ORCID-Profile: Saudatu Chinade Ja'afaru, Abu Tayab Moin

Zitieren

APA

Ja'afaru, S. C., Uzairu, A., Hossain, S., Ullah, M. H., Sallau, M. S., Ndukwe, G. I., Ibrahim, M. T., Bayil, I., & Moin, A. T. (2024). Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies. PLOS Neglected Tropical Diseases, 18(9), e0012453. https://doi.org/10.1371/journal.pntd.0012453

Vancouver

Ja'afaru SC, Uzairu A, Hossain S, Ullah MH, Sallau MS, Ndukwe GI, et al. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies. PLOS Neglected Tropical Diseases. 2024;18(9):e0012453. doi:10.1371/journal.pntd.0012453

BibTeX
@article{Jaafaru2024,
  author = {Ja'afaru, Saudatu Chinade and Uzairu, Adamu and Hossain, Sharika and Ullah, Mohammad Hamid and Sallau, Muhammed Sani and Ndukwe, George Iloegbulam and Ibrahim, Muhammad Tukur and Bayil, Imren and Moin, Abu Tayab},
  title = {Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {9},
  pages = {e0012453},
  doi = {10.1371/journal.pntd.0012453}
}
Kostenlos starten →